Navigation Links
Aegera Therapeutics Reports Survival Data from the Phase 1 Portion of its Phase 1-2 Study of AEG35156 in Combination with Sorafenib in Patients with Advanced Hepatocellular Carcinoma
Date:7/19/2010

tion and now focused on completing recruitment to the randomized Phase 2 portion of the clinical trial to confirm the therapeutic benefit of the AEG35156/sorafenib combination" stated Professor Benny Chung-Ying Zee, PhD, Director of the Centre for Clinical Trials, School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong.

For more information of the study please refers to the following trial registration: http://clinicaltrials.gov/ct2/show/NCT00882869

About AEG35156

AEG35156 is a 2nd generation antisense oligonucleotide which targets XIAP; it is designed to lower the apoptotic threshold of cancer cells, enhancing their sensitivity to intrinsic death and chemotherapy, without harming healthy cells. Patients are also being currently enrolled in a Phase 1/2 monotherapy study in CLL/indolent B-cell lymphomas, which is fully funded by The Leukemia and Lymphoma Society of North America.

About Aegera Therapeutics Inc.

Aegera Therapeutics is a clinical stage biotechnology company focused on developing novel targeted therapies that address major unmet medical needs. In addition to AEG35156, Aegera is working with its partner Human Genome Sciences (NASDAQ:HGSI) to progress HGS1029 through early stage clinical development for oncology and is also actively working on several preclinical programs in the area of autoimmune, inflammatory and central nervous system diseases. Additional information on these programs can be found on Aegera's website at '/>"/>

SOURCE AEGERA THERAPEUTICS INC.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Aegera Therapeutics phase 1/2 clinical trial results selected for oral presentation at 2008 ASH Annual Meeting
2. Aegera Therapeutics Initiates A Randomized Phase 2 Combination Study of AEG35156 for 1st Line Treatment of Non-Small Cell Lung Cancer
3. Aegera Initiates Phase 2 Clinical Trial Of AEG33773 - A Small Molecule Targeting Neuropathic Pain
4. Aegera Therapeutics Initiates a Randomized Phase 2 Study with AEG35156 for the Treatment of Hepatocellular Carcinoma
5. Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML)
6. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
7. Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics
8. Amsterdam Molecular Therapeutics Reports Half Year Results 2008
9. BN ImmunoTherapeutics Announces Partnership With National Cancer Institute
10. Arno Therapeutics Announces Appointment of Brian Lenz, CPA as Chief Financial Officer
11. CV Therapeutics Announces Ranexa(R) Named Finalist for Prix Galien USA 2008 Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Ltd. today released new data on changes in the ... outbreaks, the mean Ebola Reston gene Replikin Count (number ... 2002 was 1.1; the mean Replikin Count increased twofold ... thus predicting the current outbreaks in humans. ... be able to predict outbreaks (1).  For example, increases ...
(Date:7/30/2014)... 2014   Wyle has been named ... Mission Support Services (FILMSS) contract awarded by the ... terms of the contract, Wyle will provide mission ... Calif. In particular, Wyle will provide program and ... on the International Space Station and collaborative science ...
(Date:7/30/2014)... Vycom announces the addition of Thermax PVC ... Factory Mutual (FM) 4910 fire propagation and smoke generation ... process tools, fume hoods, furniture and cabinetry. These criteria ... wafers used in electronic chip manufacturing. , ... excellent workability and superior aesthetics. It is available in ...
(Date:7/30/2014)... , July 30, 2014 Researchers ... to interrogate biology, but such devices can do ... As such, researchers have looked to ... in vitro metabolic engineering to characterize – ... chip. New devices are envisioned to recreate animal ...
Breaking Biology Technology:Wyle Wins NASA's Fully Integrated Lifecycle Mission Support Services Contract 2Vycom Announces Flametec® Thermax PVC (FM4910 Listed) For a Variety of Clean Room Applications with Excellent Workability and Aesthetics 2UMD Researchers Bridge Gap between Microelectronics, Biological Systems 2UMD Researchers Bridge Gap between Microelectronics, Biological Systems 3UMD Researchers Bridge Gap between Microelectronics, Biological Systems 4
... 24 Favrille, Inc. (OTC,Bulletin Board: FVRL) announced today ... a reverse merger whereby Favrille would acquire,all of the ... a stock for stock merger that would result in ... transaction is,consummated on the terms set forth in the ...
... a 100% organic toxic mold remedy for mold remediation professionals and ... technology used effectively in the aftermath of the flooding in Katrina. ... ... 2008 -- Organic Environmental Technology ( http://www.organicet.com ) announced today the ...
... just five years after Jim Rider, the first American patient to ... American patient milestone. , ... Bremen, Germany (PRWEB) October ... getting worse, and the knowledge that many treatments are just not ...
Cached Biology Technology:Favrille Announces Execution of Non-binding Term Sheet for a Merger Transaction 2Katrina Proven Certified Organic Toxic Mold Remedy Now Available for Mold Remediation Professionals and Homeowners 2Katrina Proven Certified Organic Toxic Mold Remedy Now Available for Mold Remediation Professionals and Homeowners 3Katrina Proven Certified Organic Toxic Mold Remedy Now Available for Mold Remediation Professionals and Homeowners 4Stenum Hospital Does its 600th American Disc Replacement Surgery 2
(Date:7/30/2014)... decisions about what they eat, the Food and Drug ... the Nutrition Facts label found on nearly every food ... & Engineering News (C&EN), the weekly news magazine ... and the fight that has ensued. , Britt ... while the Nutrition Facts label has remained largely the ...
(Date:7/30/2014)... of major interest in neuroscience. A large number ... stages of Wallerian degeneration: transcription factor activation, immune ... expression responses in the distal segment of the ... differences in gene expression between the proximal and ... co-workers from Nantong University, China used microarrays to ...
(Date:7/30/2014)... SAN JOSE, Calif. , July 30, 2014 ... industry-academia partnership with the United States Air Force ... project proposed by Binghamton ... for human performance monitoring (HPM). The $425,000 project, ... and electronics packaging firm i3 Electronics, Inc. ( ...
Breaking Biology News(10 mins):Nano-Bio Manufacturing Consortium Awards Funding to Binghamton University for Development of Electronics and Biometric Sensor Platforms 2Nano-Bio Manufacturing Consortium Awards Funding to Binghamton University for Development of Electronics and Biometric Sensor Platforms 3
... Queen Mary, University of London reveals the many difficulties faced ... with diabetes have to invest a great deal of time ... monitoring the level of sugar in their blood, organising their ... such as negotiating relatives, input and gaining access to doctors ...
... Ottawa, Ontario (April 10, 2012) Researchers have ... childbearing age are still not achieving a folate concentration considered ... tube defects, despite a virtual absence of folate deficiency in ... nation-wide study, they found a main reason why some women ...
... to achieve goals set by the federal government for reducing ... need to eliminate an average of 64 excess calories per ... American Journal of Preventive Medicine . This reduction could ... both. Without this reduction, the authors predict that the average ...
Cached Biology News:Approach to diabetes self-management too narrow, study suggests 2Approach to diabetes self-management too narrow, study suggests 3How many calories does it take to reach childhood obesity prevention goals? 2How many calories does it take to reach childhood obesity prevention goals? 3
... in refrigerators, freezers, or liquid nitrogen. Conveniently sized to ... color coding to project, user, lab, etc. Holes in ... air circulation. Supplied with 10 x 10 (11.6 mm ... dimensions: 13 x 13 x 5.1 cm H (5 ...
Sterile glass 5 mm beads that make spreading bacterial and yeast cultures easy. Can be washed, autoclaved and reused....
Recombinant Rhesus Monkey IFN-Alpha...
REGULATED IN DEVELOPMENT AND DNA DAMAGE RESPONSES 1,HIF-1 responsive RTP801...
Biology Products: